Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This article examines the science, potential risks, and NHS guidance surrounding this off-label approach
Results: We observed a significant increase in the levels of glutamine, taurine, glutathione, and xanthine, and a significant decrease in the branched-chain amino acids, valine, and isoleucine, as well as glutamate and cysteine in the tamoxifen-resistant cells compared to tamoxifen sensitive cells
Annals of internal medicine , 177 (8), 10161027
Recalls & Warnings February 20, 2025 Maker of Zicam Agrees to Pay $6 Million to Settle Lawsuit Over Claims to Shorten Colds The maker of Zicam Cold Remedy products, Church & Dwight Co., Inc., has agreed to pay up to $6 million to settle a class action lawsuit that charged it with promoting the products to reduce the severity of cold symptoms and reduce the duration of colds without reliable scientific evidence
